Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (715)	10/8/2002 2:44:41 PM
From: Jibacoa	Read Replies (1) \| Respond to of 1005

Large Scale Biology Corporation Receives $2 Million NIST ATP Award to Develop Next-Generation Vaccine Technology VACAVILLE, Calif.--(BUSINESS WIRE)--Oct. 8, 2002--Large Scale Biology Corporation (Nasdaq:LSBC - News) today announced receipt of a three-year, $2 million award from the National Institute of Standards and Technology (NIST) Advanced Technology Program (ATP) to develop a new vaccine discovery and production platform. The award is expected to accelerate the development of a new generation of GENEWARE®, the Company's proprietary gene expression technology, with a focus on novel and more effective vaccines. biz.yahoo.com Bernard